IS7969A - Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi - Google Patents
Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfiInfo
- Publication number
- IS7969A IS7969A IS7969A IS7969A IS7969A IS 7969 A IS7969 A IS 7969A IS 7969 A IS7969 A IS 7969A IS 7969 A IS7969 A IS 7969A IS 7969 A IS7969 A IS 7969A
- Authority
- IS
- Iceland
- Prior art keywords
- pyridine derivatives
- derivatives useful
- exchange systems
- calcium exchange
- inhibiting sodium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20030030A FI20030030A0 (fi) | 2003-01-09 | 2003-01-09 | Uusia yhdisteitä |
| PCT/FI2004/000011 WO2004063191A1 (en) | 2003-01-09 | 2004-01-09 | Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7969A true IS7969A (is) | 2005-08-02 |
Family
ID=8565286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7969A IS7969A (is) | 2003-01-09 | 2005-08-02 | Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7482340B2 (is) |
| EP (1) | EP1583759A1 (is) |
| JP (1) | JP2006516271A (is) |
| KR (1) | KR20050095601A (is) |
| CN (1) | CN100457752C (is) |
| AR (1) | AR042733A1 (is) |
| AU (1) | AU2004203943B2 (is) |
| BR (1) | BRPI0406669A (is) |
| CA (1) | CA2512184A1 (is) |
| EA (1) | EA008539B1 (is) |
| FI (1) | FI20030030A0 (is) |
| HR (1) | HRP20050703A2 (is) |
| IL (1) | IL169435A0 (is) |
| IS (1) | IS7969A (is) |
| MX (1) | MXPA05007435A (is) |
| NO (1) | NO20053730L (is) |
| NZ (1) | NZ541087A (is) |
| PL (1) | PL378326A1 (is) |
| RS (1) | RS20050528A (is) |
| UA (1) | UA81941C2 (is) |
| WO (1) | WO2004063191A1 (is) |
| ZA (1) | ZA200505461B (is) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20011507A0 (fi) * | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
| KR101233223B1 (ko) * | 2004-12-21 | 2013-02-14 | 제이엔씨 석유 화학 주식회사 | 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자 |
| EP2125734A2 (en) * | 2007-02-22 | 2009-12-02 | Syngeta Participations AG | Novel microbiocides |
| EA023768B1 (ru) * | 2010-12-06 | 2016-07-29 | Отифони Терапеутикс Лимитед | ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ |
| EP2524908A1 (en) | 2011-05-20 | 2012-11-21 | LEK Pharmaceuticals d.d. | Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds |
| DK2567958T3 (en) | 2011-09-12 | 2015-02-02 | Sanofi Sa | Substituted 2- (chroman-6-yloxy) thiazoles and their use as medicaments |
| CA2846347C (en) | 2011-09-12 | 2019-05-21 | Sanofi | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| US8912224B2 (en) | 2011-09-12 | 2014-12-16 | Sanofi | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| JP5941637B2 (ja) * | 2011-09-12 | 2016-06-29 | サノフイ | 置換２−（クロマン−６−イルオキシ）−チアゾール及び医薬としてのその使用 |
| WO2013144191A1 (de) * | 2012-03-29 | 2013-10-03 | Bayer Intellectual Property Gmbh | Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen |
| TWI633095B (zh) * | 2013-03-08 | 2018-08-21 | 賽諾菲公司 | 經取代－６－基氧基－環烷類及其作為醫藥品之用途 |
| GB201416186D0 (en) | 2014-09-12 | 2014-10-29 | Redx Pharma Ltd | Compounds |
| SG11201707246YA (en) | 2015-03-06 | 2017-10-30 | Pharmakea Inc | Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof |
| CN107624110B (zh) | 2015-03-06 | 2021-01-26 | 法玛克亚公司 | 赖氨酰氧化酶样2抑制剂及其用途 |
| WO2017030169A1 (ja) * | 2015-08-19 | 2017-02-23 | 日産化学工業株式会社 | 液晶配向剤などに用いられる新規なイミド系重合体 |
| EP3509594A4 (en) | 2016-09-07 | 2020-05-06 | Pharmakea, Inc. | USE OF A LYSYLOXIDASE-LIKE 2 INHIBITOR |
| SG11201901999XA (en) | 2016-09-07 | 2019-04-29 | Pharmakea Inc | Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making |
| WO2019175464A1 (en) | 2018-03-14 | 2019-09-19 | Orion Corporation | Compounds useful as inhibitors of sodium-calcium exchanger (ncx) |
| BR112023001557A2 (pt) | 2020-07-28 | 2023-04-04 | Jazz Pharmaceuticals Ireland Ltd | Inibidores de raf bicíclicos fundidos e métodos para uso dos mesmos |
| CN115850258A (zh) * | 2022-12-27 | 2023-03-28 | 东北林业大学 | 一种马赛替尼的合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2820817A (en) | 1954-02-04 | 1958-01-21 | Mcneilab Inc | Oxygenated indan compounds and method of making the same |
| US3862232A (en) | 1963-07-03 | 1975-01-21 | Upjohn Co | 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof |
| BE650081A (is) | 1963-07-03 | |||
| GB1154119A (en) | 1968-05-20 | 1969-06-04 | Merck Ag E | 3-Alkyl-Flavanones |
| JPH04113839A (ja) * | 1990-09-05 | 1992-04-15 | Mitsubishi Petrochem Co Ltd | ポリカーボネート樹脂積層物 |
| FR2733685B1 (fr) | 1995-05-05 | 1997-05-30 | Adir | Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant |
| JPH0967336A (ja) | 1995-09-04 | 1997-03-11 | Kanebo Ltd | 新規なイソチオウレア誘導体 |
| DE69810606T2 (de) | 1997-03-27 | 2003-10-09 | Taisho Pharmaceutical Co Ltd | 2-phenoxyanilinderivate |
| JPH1149752A (ja) * | 1997-08-05 | 1999-02-23 | Taisho Pharmaceut Co Ltd | フェノキシピリジン誘導体 |
| DE19742508A1 (de) | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
| CN1127476C (zh) | 1997-10-20 | 2003-11-12 | 大正制药株式会社 | 2－苯氧基苯胺衍生物 |
| JPH11302235A (ja) | 1998-04-15 | 1999-11-02 | Taisho Pharmaceut Co Ltd | フェノキシアルキルアミン誘導体 |
| EP1180029A4 (en) | 1999-04-23 | 2002-10-02 | Bristol Myers Squibb Co | BICYCLIC ACYL IHIBITORING SODIUM / PROTON EXCHANGER AND RELATED PROCEDURE. |
| EP1212314B1 (en) * | 1999-09-17 | 2005-11-30 | Nissan Chemical Industries, Ltd. | Benzopyran derivative |
| FI20011507A0 (fi) * | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
-
2003
- 2003-01-09 FI FI20030030A patent/FI20030030A0/fi unknown
-
2004
- 2004-01-08 AR ARP040100052A patent/AR042733A1/es unknown
- 2004-01-09 JP JP2006500151A patent/JP2006516271A/ja active Pending
- 2004-01-09 RS YUP-2005/0528A patent/RS20050528A/sr unknown
- 2004-01-09 EA EA200501104A patent/EA008539B1/ru not_active IP Right Cessation
- 2004-01-09 NZ NZ541087A patent/NZ541087A/en unknown
- 2004-01-09 PL PL378326A patent/PL378326A1/pl not_active Application Discontinuation
- 2004-01-09 MX MXPA05007435A patent/MXPA05007435A/es active IP Right Grant
- 2004-01-09 EP EP04701023A patent/EP1583759A1/en not_active Withdrawn
- 2004-01-09 AU AU2004203943A patent/AU2004203943B2/en not_active Ceased
- 2004-01-09 CA CA002512184A patent/CA2512184A1/en not_active Abandoned
- 2004-01-09 KR KR1020057012621A patent/KR20050095601A/ko not_active Application Discontinuation
- 2004-01-09 CN CNB200480003357XA patent/CN100457752C/zh not_active Expired - Fee Related
- 2004-01-09 WO PCT/FI2004/000011 patent/WO2004063191A1/en active Application Filing
- 2004-01-09 BR BR0406669-3A patent/BRPI0406669A/pt not_active IP Right Cessation
- 2004-01-09 US US10/541,677 patent/US7482340B2/en not_active Expired - Fee Related
- 2004-09-01 UA UAA200507847A patent/UA81941C2/uk unknown
-
2005
- 2005-06-28 IL IL169435A patent/IL169435A0/en unknown
- 2005-08-02 IS IS7969A patent/IS7969A/is unknown
- 2005-08-03 NO NO20053730A patent/NO20053730L/no not_active Application Discontinuation
- 2005-08-08 HR HR20050703A patent/HRP20050703A2/hr not_active Application Discontinuation
-
2006
- 2006-01-24 ZA ZA200505461A patent/ZA200505461B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060241147A1 (en) | 2006-10-26 |
| AU2004203943A1 (en) | 2004-07-29 |
| CN1745078A (zh) | 2006-03-08 |
| AU2004203943B2 (en) | 2009-09-17 |
| EA200501104A1 (ru) | 2005-12-29 |
| NO20053730L (no) | 2005-10-07 |
| ZA200505461B (en) | 2006-03-29 |
| NZ541087A (en) | 2008-04-30 |
| CN100457752C (zh) | 2009-02-04 |
| JP2006516271A (ja) | 2006-06-29 |
| EP1583759A1 (en) | 2005-10-12 |
| US7482340B2 (en) | 2009-01-27 |
| MXPA05007435A (es) | 2005-09-12 |
| IL169435A0 (en) | 2007-07-04 |
| HRP20050703A2 (en) | 2005-10-31 |
| FI20030030A0 (fi) | 2003-01-09 |
| BRPI0406669A (pt) | 2005-12-20 |
| KR20050095601A (ko) | 2005-09-29 |
| UA81941C2 (uk) | 2008-02-25 |
| NO20053730D0 (no) | 2005-08-03 |
| WO2004063191A1 (en) | 2004-07-29 |
| CA2512184A1 (en) | 2004-07-29 |
| AR042733A1 (es) | 2005-06-29 |
| EA008539B1 (ru) | 2007-06-29 |
| RS20050528A (en) | 2007-06-04 |
| PL378326A1 (pl) | 2006-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7969A (is) | Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi | |
| FIC20230013I1 (fi) | Sofosbuviiri tai sen suola tai missä tahansa muussa muodossa, joka on suojattu peruspatentilla EP3904365 | |
| HUS1900052I1 (hu) | 2-acilaminotiazol-származékok vagy sóik | |
| IL192053A0 (en) | 2-adamantylurea derivatives as selective 11??-hsd1 inhibitors | |
| GB2424132B (en) | High-temperature memory systems | |
| ZA200500621B (en) | 2-cyano-4-fluoropyrrolidine derivative or its salt | |
| IS8345A (is) | 6-útskipt anilínópúrín sem RTK-tálmar | |
| DK2094263T3 (da) | 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer | |
| IS7884A (is) | Díasepínóindól afleiður sem kínasa hindrar | |
| IS8001A (is) | Bíarýl setin tríasól sem natríum ganga tálmar | |
| EP1577787A4 (en) | REAL-TIME SYSTEM WebSharing | |
| IS7939A (is) | Pýrasólpýridín afleiður | |
| NO20052733D0 (no) | C-6 modifiserte indazolylpyrrolotriaziner | |
| AU2003300813A8 (en) | Thermal barrier coating having low thermal conductivity | |
| DE60238980D1 (de) | Verbesserungen in Funkortungsystemen | |
| AU2003275073A8 (en) | Low temperature geothermal system | |
| HK1174910A1 (en) | Water-soluble tetrazolium salts | |
| EP1601527A4 (en) | HEAT LOCK COATING WITH LOW THERMAL CONDUCTIVITY | |
| IS7318A (is) | Tríasól-kínólínafleiður sem eru gagnlegar sem adenósínviðtakabindlar | |
| GB2397086B (en) | Flood protection system | |
| EP1654509A4 (en) | HEAT TRANSFER SYSTEMS | |
| EP1623972A4 (en) | SOLID N-ACYLALANINE OR SALTS THEREOF | |
| GB0314864D0 (en) | Flood barrier | |
| GB0303465D0 (en) | Flood Barrier | |
| HK1079194A1 (en) | Dipyridodiazepinones as reverse transcriptase inhibitors |